Harbour Investments, Inc. Blueprint Medicines Corp Transaction History
Harbour Investments, Inc.
- $3.14 Billion
- Q3 2024
A detailed history of Harbour Investments, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Harbour Investments, Inc. holds 200 shares of BPMC stock, worth $19,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$19,296
Previous $21,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BPMC
# of Institutions
352Shares Held
60.3MCall Options Held
2.25MPut Options Held
1.18M-
Vanguard Group Inc Valley Forge, PA6.68MShares$645 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$641 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.39MShares$520 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA3.96MShares$383 Million0.07% of portfolio
-
State Street Corp Boston, MA2.77MShares$267 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.76B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...